Profil
Yvon Cormier is the founder of Asmacure Ltée, which was founded in 2002.
He held the title of President & Chief Medical Officer from 2007 to 2009.
Dr. Cormier's former jobs include being an Associate Dean at Université Laval from 2010 to 2010, a Member at American Thoracic Society, Inc., and President-Canadian Thoracic Society at Canadian Lung Association.
Dr. Cormier's education history includes an undergraduate degree from Université de Moncton and a doctorate from Université Laval.
Ehemalige bekannte Positionen von Yvon Cormier
| Unternehmen | Position | Ende |
|---|---|---|
Université Laval
Université Laval Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01.01.2010 |
Canadian Lung Association
Canadian Lung Association Miscellaneous Commercial ServicesCommercial Services Operates as a national organization and volunteer-based health charity | Corporate Officer/Principal | - |
American Thoracic Society, Inc.
American Thoracic Society, Inc. Miscellaneous Commercial ServicesCommercial Services Profession membership organization for thoracic surgeons. | Corporate Officer/Principal | - |
Asmacure Ltée
Asmacure Ltée Pharmaceuticals: MajorHealth Technology Develops novel, proprietary compounds that target cholinergic receptors for the treatment of inflammation, notably pulmonary airway diseases | Gründer | - |
Ausbildung von Yvon Cormier
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Université de Moncton
Université de Moncton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Université Laval
Université Laval Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Asmacure Ltée
Asmacure Ltée Pharmaceuticals: MajorHealth Technology Develops novel, proprietary compounds that target cholinergic receptors for the treatment of inflammation, notably pulmonary airway diseases | Health Technology |
American Thoracic Society, Inc.
American Thoracic Society, Inc. Miscellaneous Commercial ServicesCommercial Services Profession membership organization for thoracic surgeons. | Commercial Services |
Canadian Lung Association
Canadian Lung Association Miscellaneous Commercial ServicesCommercial Services Operates as a national organization and volunteer-based health charity | Commercial Services |
















